analyst
CR
NASDAQ · CRMD
CorMedix Inc.
Healthcare · Biotechnology
$5.27
Up+$0.19 (+3.74%)
Updated Nov 21, 2026, 9:35 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 924.2M
- P/E ratio
- 5.48
- Dividend yield
- 0.00%
- 52-week range
- $4.47 – $9.09
- Volume
- 3.61M
- Avg. volume
- 2.73M
Price performance · CRMD
CRMD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 20, 2026
CRMD closed at $5.27 after 21 trading sessions, down 32.87% for the selected period.
- Last close
- $5.27
- Period change
- -32.87%
- Period low
- $4.50
- Period high
- $8.20
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | $4.96 | $5.315 | $4.95 | $5.27 | 3.61M |
| Nov 19, 2026 | $4.57 | $5.155 | $4.465 | $5.08 | 3.55M |
| Nov 18, 2026 | $4.65 | $4.71 | $4.485 | $4.50 | 1.6M |
| Nov 17, 2026 | $4.79 | $4.87 | $4.635 | $4.67 | 1.99M |
| Nov 16, 2026 | $5.05 | $5.2331 | $4.75 | $4.82 | 3.2M |
| Nov 13, 2026 | $4.88 | $5.055 | $4.65 | $4.66 | 2.39M |
| Nov 12, 2026 | $5.15 | $5.49 | $4.815 | $4.84 | 3.68M |
| Nov 11, 2026 | $5.33 | $5.42 | $5.24 | $5.30 | 1.63M |
| Nov 10, 2026 | $5.49 | $5.675 | $5.29 | $5.37 | 2.34M |
| Nov 9, 2026 | $5.47 | $5.56 | $5.16 | $5.47 | 2.33M |
| Nov 6, 2026 | $5.25 | $5.335 | $5.10 | $5.32 | 1.62M |
| Nov 5, 2026 | $5.75 | $5.77 | $5.2114 | $5.23 | 1.83M |
| Nov 4, 2026 | $5.71 | $5.79 | $5.58 | $5.66 | 1.49M |
| Nov 3, 2026 | $5.35 | $5.60 | $5.30 | $5.56 | 2.46M |
| Nov 2, 2026 | $5.70 | $5.75 | $5.34 | $5.39 | 3.3M |
| Oct 30, 2026 | $7.68 | $7.68 | $5.63 | $5.695 | 7.02M |
| Oct 29, 2026 | $8.34 | $8.3545 | $7.455 | $7.64 | 1.89M |
| Oct 28, 2026 | $7.95 | $8.22 | $7.90 | $8.20 | 1.16M |
| Oct 27, 2026 | $7.91 | $8.11 | $7.80 | $8.00 | 1M |
| Oct 26, 2026 | $8.06 | $8.09 | $7.7622 | $7.94 | 1.13M |
| Oct 23, 2026 | $8.01 | $8.11 | $7.79 | $7.85 | 894.54K |
Latest CRMD news
The latest Smart Investors Daily articles mentioning CRMD.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

